Oxytocin (OT) in the central nervous system (CNS) influences social cognition and behavior,
making it a candidate for treating clinical disorders such as schizophrenia and autism …

Generalized social anxiety disorder (GSAD) is characterized by aberrant patterns of
amygdala-frontal connectivity to social signals of threat and at rest. The neuropeptide …

Intranasal delivery of oxytocin (Oxt) has been identified as a potential therapeutic to target
human conditions characterized by social deficits, yet the ability of this administrative route …

Following the discovery that intranasal administration of neuropeptides can reach the central
nervous system, a growing number of studies applied intranasal oxytocin (OT) paradigms to …

Oxytocin may influence various human behaviors and the connectivity across subcortical
and cortical networks. Previous oxytocin studies are male biased and often constrained by …

Accumulating evidence demonstrates the important role of oxytocin (OT) in the modulation of
social cognition and behavior. This has led many to suggest that the intranasal …

Social dysfunction is a core symptom of many psychiatric disorders and current medications
have little or no remedial effects on this. Following on from extensive studies on animal …

Many studies have highlighted the potential of oxytocin (OT) to enhance facial affect
recognition in healthy humans. However, inconsistencies have emerged with regard to the …

There is evidence of the therapeutic potential of intranasal oxytocin for the treatment of pain
and various psychiatric disorders, however, there is scant evidence that oxytocin reaches …

Social relationships protect against the development of stress-related psychiatric disorders,
yet little is known about the neurobiology that regulates this phenomenon. Recent evidence …